Patent Assignment
Reel/Frame 026577/0808
RELEASE OF SECURITY INTEREST RECORDED AT REEL/FRAME 25434/870
Recorded: 2011-07-12
Received: 2011-07-12
Pages: 8
Assignor
JPMORGAN CHASE BANK N.A., AS ADMINISTRATIVE AGENT
Executed: 2011-06-17
Assignee
PENWEST PHARMACEUTICALS CO.
100 ENDO BOULEVARD C/O ENDO PHARMACEUTICALS INC., CHADDS FORD, PA, 19317, UNITED STATES
Covered Applications
(20)
Synthesis of Alpha-Tocopherolquinone Derivatives, and Methods of Using the Same
App. No. 61/312,185
→
Chronotherapeutic dosage forms
App. No. 12/380,642
→
SUSTAINED RELEASE FORMULATIONS OF NALBUPHINE
App. No. 12/154,496
→
Sustained release formulations of oxymorphone
App. No. 11/891,775
→
SUSTAINED RELEASE MATRIX SYSTEMS FOR HIGHLY SOLUBLE DRUGS
App. No. 11/729,024
→
METHODS FOR TREATING PAIN WITH OPIOID FORMULATIONS HAVING REDUCED POTENTIAL FOR ABUSE
App. No. 11/704,848
→
Robust sustained release formulations of oxymorphone
App. No. 11/546,129
→
Robust sustained release formulations of oxymorphone and methods of use thereof
App. No. 11/546,128
→
Robust sustained release formulations
App. No. 11/545,954
→
Sustained release formulations of nalbuphine
App. No. 11/509,347
→
Ethanol-resistant sustained release formulations
App. No. 11/370,699
→
CHRONOTHERAPEUTIC DOSAGE FORMS AND METHODS OF TREATMENT USING CHRONOTHERAPY
App. No. 11/001,675
→
DELAYED RELEASE DOSAGE FORMS
App. No. 10/943,356
→
SUSTAINED RELEASE FORMULATIONS OF METFORMIN
App. No. 10/630,239
→
NOVEL ONCE-A-DAY CONTROLLED RELEASE SULFONYLUREA FORMULATION
App. No. 10/396,114
→
OPIOID FORMULATIONS HAVING REDUCED POTENTIAL FOR ABUSE
App. No. 10/254,207
→
SUSTAINED RELEASE FORMULATIONS OF OXYMORPHONE
App. No. 10/189,932
→
CONTROLLED RELEASE INSUFFLATION CARRIER FOR MEDICAMENTS
App. No. 10/047,060
→
SUSTAINED RELEASE HETERODISPERSE HYDROGEL SYSTEMS-AMORPHOUS DRUGS
App. No. 09/879,296
→
SUSTAINED RELEASE MATRIX FOR HIGH-DOSE INSOLUBLE DRUGS
App. No. 09/842,289
→